A Sensitive Virus Discovery Assay for Respiratory Clinical Samples
Author Information
Author(s): de Vries Michel, Deijs Martin, Canuti Marta, van Schaik Barbera D. C., Faria Nuno R., van de Garde Martijn D. B., Jachimowski Loes C. M., Jebbink Maarten F., Jakobs Marja, Luyf Angela C. M., Coenjaerts Frank E. J., Claas Eric C. J., Molenkamp Richard, Koekkoek Sylvie M., Lammens Christine, Leus Frank, Goossens Herman, Ieven Margareta, Baas Frank, van der Hoek Lia
Primary Institution: Academic Medical Center of the University of Amsterdam
Hypothesis
Can the VIDISCA method be optimized to enhance the sensitivity of virus detection in respiratory samples?
Conclusion
The optimization of the VIDISCA method significantly enhances its sensitivity, allowing for better detection of respiratory viruses in clinical samples.
Supporting Evidence
- VIDISCA-454 identified the proper virus in 11 out of 18 samples tested.
- The median viral load in VIDISCA-454 positive samples was 7.2 E5 viral genome copies/ml.
- Optimization steps included using non-rRNA-annealing hexamers and rRNA-blocking oligos.
Takeaway
Researchers improved a virus detection method to find more viruses in sick kids' noses, helping doctors know what's making them sick.
Methodology
The study optimized the VIDISCA method by using non-rRNA-annealing hexamers and rRNA-blocking oligos during reverse transcription, and by employing high-throughput sequencing.
Limitations
The study could not compare the optimized VIDISCA-454 with the traditional method due to limited respiratory clinical specimens.
Participant Demographics
Participants were children with respiratory infections, randomly selected from a larger study.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website